Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of buffers

AUTOR(ES)

Gehlbach, Brian K

FONTE

BioMed Central

RESUMO

The recognition and management of acid–base disorders is a commonplace activity for intensivists. Despite the frequency with which non-bicarbonate-losing forms of metabolic acidosis such as lactic acidosis occurs in critically ill patients, treatment is controversial. This article describes the properties of several buffering agents and reviews the evidence for their clinical efficacy. The evidence supporting and refuting attempts to correct arterial pH through the administration of currently available buffers is presented.

Documentos Relacionados

• Bench-to-bedside review: Treating acid–base abnormalities in the intensive care unit – the role of renal replacement therapy
• Bench-to-bedside review: A brief history of clinical acid–base
• Bench-to-bedside review: Mobilizing patients in the intensive care unit – from pathophysiology to clinical trials
• Bench-to-bedside review: Cytopathic hypoxia
• Bench-to-bedside review: Lactate and the kidney